in

Brokers' take: Analysts raise target prices for Raffles Medical amid outperformance

ANALYSTS are raising their target prices for Raffles Medical Group, after the healthcare services provider beat consensus estimates to post a stellar set of H1 results on the back of a protracted recovery from the Covid-19 pandemic.

Reference